Filing metadata

Accession number
0001140361-23-023022
Form type
Form 4
Filer
4D Molecular Therapeutics, Inc.
CIK
CIK 1650648
Filed
May 04, 2023
Reporting period
May 02, 2023
Description
Insider transaction

Explore SEC Filings Hub